Exploring new approaches to the treatment of asthma: Potential roles for lipoxins and aspirin-triggered lipid mediators

Drugs of Today

Volumn 39, Issue 5, 2003, Pages 373-384

  Levy, Bruce D ^a   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ACETYLSALICYLIC ACID; ADENYLATE CYCLASE ACTIVATOR; ANTIASTHMATIC AGENT; ARACHIDONATE 15 LIPOXYGENASE; CALCIMYCIN; CHEMOKINE; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; FORSKOLIN; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; LEUKOTRIENE; LEUKOTRIENE A4; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPID; LIPOXIN; LIPOXIN A; LIPOXIN B; MESSENGER RNA; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; PROSTAGLANDIN D2 DERIVATIVE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; DRUG RESEARCH; EXPERIMENTAL MODEL; HUMAN; LEUKOCYTE; MEDIATOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 0038037241     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2003.39.5.740217     Document Type: Review

References (46)

1. Leff, A.R. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am J Resp Crit Care Med 2000, 161: S125-32.
2. Bousquet, J., Jeffery, P.K., Busse, W.W., Johnson, M., Vignola, A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Resp Crit Care Med 2000, 161: 1720-45.
3. Robinson, D.S., Hamid, Q., Ying, S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326: 298-304.
4. Samuelsson, B. In: Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures. Almqvist & Wiksell: Stockholm 1982, 153-74.
5. Drazen, J.M., Austen, K.F. State of Art. Leukotrienes and airway responses. Am Rev Respir Dis 1987, 136: 985-98.
6. Serhan, C.N., Haeggstrom, J.Z., Leslie, C.C. Lipid mediator networks in cell signaling: Update and impact of cytokines. FASEB J 1996, 10: 1147-58.
7. 4. Clin Biochem 1990, 23: 459-68.
8. Serhan, C.N. In: Inflammation: Basic Principles and Clinical Correlates. J.I. Gallin and R. Snyderman (Eds.). Lippincott Williams & Wilkins: Philadelphia 1999, 373-85.
9. Lee, T.H., Crea, A.E., Gant, V. et al. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 1990, 141: 1453-8.
10. Badr, K.F., DeBoer, D.K., Schwartzberg, M., Serhan, C.N. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: Evidence for competition at a common receptor. Proc Natl Acad Sci USA 1989, 86: 3438-42.
11. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K., Serhan, C.N. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat Immunol 2001, 2: 612-9.
12. Gronert, K., Martinsson-Niskanen, T., Ravasi, S., Chiang, N., Serhan, C.N. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am J Pathol 2001, 158: 3-9.
13. Takano, T., Fiore, S., Maddox, J.F., Brady, H.R., Petasis, N.A., Serhan, C.N. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors. J Exp Med 1997, 185: 1693-704.
14. Shen, J., Herderick, E., Cornhill, J.F. et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 1996, 98: 2201-8.
15. Munger, K.A., Montero, A., Fukunaga, M. et al. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc Natl Acad Sci USA 1999, 96: 13375-80.
16. Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., Brady, H.R. Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 2000, 164: 1663-7.
17. Serhan, C.N., Hong, S., Gronert, K. et al. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196: 1025-37.
18. Bandeira-Melo, C., Serra, M.F., Diaz, B.L. et al. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: Relationship with concurrent eosinophilia. J Immunol 2000, 164: 1029-36.
19. Levy, B.D., De Sanctis, G.T., Devchand, P.R. et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A (4). Nat Med 2002, 8: 1018-23.
20. Edenius, C., Kumlin, M., Bjork, T., Anggard, A., Lindgren, J.A. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Letters 1990, 272: 25-8.
21. Levy, B.D., Bertram, S., Tai, H.H. et al. Agonist-induced lipoxin A4 generation: Detection by a novel lipoxin A-4-ELISA. Lipids 1993, 28: 1047-53.
22. Sanak, M., Levy, B.D., Clish, C.B. et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Resp J 2000, 16: 44-9.
23. Bonnans, C., Vachier, I., Chavis, C., Godard, P., Bousquet, J., Chanez, P. Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med 2002, 165: 1531-5.
24. Clish, C.B., Levy, B.D., Chiang, N., Tai, H.H., Serhan, C.N. Oxidoreductases in lipoxin A4 metabolic inactivation: A novel role for 15-oxoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J Biol Chem 2000, 275: 25372-80.
25. Jenkinson, S.G., Banschbach, M.W. Radioimmunoassay determinations of prostaglandin E in pleural effusions of varying causes. Am Rev Respir Dis 1982, 126: 21-4.
26. Borrelli, E., Montmayeur, J.P., Foulkes, N.S., Sassone-Corsi, P. Signal transduction and gene control: The cAMP pathway. Crit Rev Oncog 1992, 3: 321-38.
27. Thiele, B.J., Berger, M., Huth, A., Reimann, I., Schwarz, K., Thiele, H. Tissue-specific translational regulation of alternative rabbit 15-lipoxygenase mRNAs differing in their 3′-untranslated regions. Nucleic Acids Res 1999, 27: 1828-36.
28. Kritzik, M.R., Ziober, A.F., Dicharry, S., Conrad, D.J., Sigal, E. Characterization and sequence of an additional 15-lipoxygenase transcript and of the human gene. Biochim Biophys Acta 1997, 1352: 267-81.
29. Kapff, C.T., Jandl, J.H. Blood. Atlas and Sourcebook of Hematology. Second Ed. Little, Brown and Co.: Boston 1991.
30. Beaulieu, A.D., Paquin, R., Rathanaswami, P., McColl, S.R. Nuclear signaling in human neutrophils. Stimulation of RNA synthesis is a response to a limited number of proinflammatory agonists. J Biol Chem 1992, 267: 426-32.
31. Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N., Gronert, K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000, 192: 1197-204.
32. Jones, T.R., Labelle, M., Belley, M. et al. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 1995, 73: 191-201.
33. De Bie, J.J., Hessel, E.M., Van Ark, I. et al. Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br J Pharmacol 1996, 119: 1484-90.
34. Trifilieff, A., El-Hashim, A., Bertrand, C. Time course of inflammatory and remodeling events in a murine model of asthma: Effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 2000, 279: L1120-8.
35. Christie, P.E., Spur, B.W., Lee, T.H. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis 1992, 145: 1281-4.
36. Dahlen, S.E., Veale, C.A., Webber, S.E., Marron, B.E., Nicolaou, K.C., Serhan, C.N. Pharmacodynamics of lipoxin A4 in airway smooth muscle. Agents Actions 1989, 26: 93-5.
37. Resnati, M., Pallavicini, I., Wang, J.M. et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL 1/LXA4R. Proc Natl Acad Sci USA 2002, 99: 1359-64.
38. Soyombo, O., Spur, B.W., Lee, T.H. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 1994, 49: 230-4.
39. Bandeira-Melo, C., Bozza, P.T., Diaz, B.L. et al. Cutting edge: Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol 2000, 164: 2267-71.
40. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C.N., Sher, A. Lipoxin-mediated inhibition of IL-12 production by DCs: A mechanism for regulation of microbial immunity. Nat Immunol 2002, 3: 76-82.
41. Bryan, S.A., O'Connor, B.J., Matti, S. et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356: 2149-53.
42. Leckie, M.J., ten Brinke, A., Khan, J. et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356: 2144-8.
43. Perretti, M., Chiang, N., La, M. et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 2002, 8: 1296-302.
44. Holgate, S.T. The epidemic of allergy and asthma. Nature 1999, 402(Suppl. 6760): B2-4.
45. Drazen, J.M., Silverman, E.K., Lee, T.H. Heterogeneity of therapeutic responses in asthma. Brit Med Bull 2000, 56: 1054-70.
46. Clish, C.B., O'Brien, J.A., Gronert, K., Stahl, G.L., Petasis, N.A., Serhan, C.N. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci USA 1999, 96: 8247-52.